Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas

BACKGROUND: Prognosis of children with primary disseminated or metastatic relapsed sarcomas remains dismal despite intensification of conventional therapies including high-dose chemotherapy. Since haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is effective in the treatment of he...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichholz, Thomas, Döring, Michaela, Giardino, Stefano, Gruhn, Bernd, Seitz, Christian, Flaadt, Tim, Schwinger, Wolfgang, Ebinger, Martin, Holzer, Ursula, Mezger, Markus, Teltschik, Heiko-Manuel, Sparber-Sauer, Monika, Koscielniak, Ewa, Abele, Michael, Handgretinger, Rupert, Lang, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990259/
https://www.ncbi.nlm.nih.gov/pubmed/36895486
http://dx.doi.org/10.3389/fonc.2023.1064190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990259/
https://www.ncbi.nlm.nih.gov/pubmed/36895486
http://dx.doi.org/10.3389/fonc.2023.1064190

Ejemplares similares